We’ve searched the ASX for the lowest-cost funds, helping you invest wisely while keeping more of your money working for you.

Are you looking for investment growth without all the monitoring and activity that growth portfolios usually require? Well, ...

Oklo, Inc. OKLO is slated to report fourth-quarter 2024 results on March 24, after market close. Stay up-to-date with all ...

Personally, my favorite stock, the single one that I would hold if I couldn't own any others, is Costco ( COST 0.58%). This ...

If you can tune out the near-term noise and want some Buffett-backed stocks to hold for the long haul, you should consider ...

When private equity managers 'buy' an asset, the real fun begins - the opportunity to add value. Neuberger Berman's Gabriel ...

The Betashares Nasdaq 100 ETF provides investors with exposure to 100 of the largest non-financial companies listed on the ...

Snap advances in AR and benefits from advertising revenue growth, but competition and regional pressures suggest investors ...

Canaccord analyst Elyse Shapiro upgraded Nanosonics (NNCSF) to Buy from Hold with a price target of A$4.74, up from A$4.47. FDA De Novo ...

Canadian National Railway ( TSX:CNR) is down more than 20% in the past 12 months. Contrarian TSX investors are wondering if ...

Welcome on into the Positional Buy Sell Hold series where each week I’ll be focusing on one position to analyze four players ...

Canaccord analyst Tania Armstrong-Whitworth downgraded Knight Therapeutics (KHTRF) to Hold from Buy with a C$6.50 price target Light Up your ...